Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: Bob L who wrote (4493)	8/20/2001 2:21:13 PM
From: Biomaven	Respond to of 52153

Dickinson's reports the proposed new Chief Counsel for the FDA: New FDA Chief Counsel is 1st Amendment Scholar The Bush Administration chooses for FDA's next chief counsel Daniel E. Troy, a private practice attorney with expertise in an FDA weakness: First Amendment issues. fdaweb.com This looks like him: aei.org Clerked for Bork, AEI scholar, doesn't appear from his resume like he knows what the letters "IND" or "NDA" stand for. Looks like they went with Republican credentials rather than FDA expertise. Too bad they couldn't simply find somebody with both. At least he'll likely rein in the out-of-control FDA advertising police - last thing I saw they were going after companies for distributing info about non-approved drugs at medical conferences. Peter